As of 28 Aug 2026, Emcure Pharmaceuticals Ltd share price is ₹1,879.30. The stock opened at ₹1,879.30 and had closed at ₹1,862.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,260.10 and a high of ₹2,047.40. In terms of performance, Emcure Pharmaceuticals Ltd share price has increased by 31.34% over the past six months and has increased by 35.03% over the last year.
EMCURE Charts
Emcure Pharmaceuticals Ltd Overview
About EMCURE
Emcure Pharmaceuticals is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally.
Emcure Pharmaceuticals Ltd Historical Performance
Emcure Pharmaceuticals Ltd Fundamental Analysis
Emcure Pharmaceuticals Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 1,475.96 | 1,494.64 | 1,556.61 | 1,283.35 | 1,118.09 |
| EBITDA | 364.62 | 406.18 | 409.66 | 247.34 | 246.03 |
| Net Profit | 200.11 | 233.70 | 258.85 | 117.62 | 122.79 |
| EPS | 10.55 | 12.33 | 13.65 | 6.21 | 6.48 |
Emcure Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 44.07 |
| MACD | -4.94 |
| 20-Day SMA | 1,929.06 |
Emcure Pharmaceuticals Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Emcure Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Emcure Pharmaceuticals Ltd today is ₹1,879.30 on NSE and ₹1,879.30 on BSE.
- The 52-week high of Emcure Pharmaceuticals Ltd is ₹2,047.40, while the 52-week low is ₹1,260.10.
- The current market capitalisation of Emcure Pharmaceuticals Ltd is approximately ₹35,647 crore.
- The P/E (Price-to-Earnings) ratio of Emcure Pharmaceuticals Ltd is 31.10. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Emcure Pharmaceuticals Ltd is 5.87. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Emcure Pharmaceuticals Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Emcure Pharmaceuticals Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Emcure Pharmaceuticals Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Emcure Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 77.83% promoters, -1.99% FIIs, 8.46% DIIs, and 6.45% public shareholders.
